HCV Test Explained: Hepatitis C Symptoms, Spread & Report (India 2026)| HCV टेस्ट गाइड

HCV Test (Hepatitis C) Explained: Anti-HCV vs HCV RNA, Positive Result Meaning & Curative Treatment (India 2026)

HCV टेस्ट गाइड: Anti-HCV vs HCV RNA, पॉजिटिव रिजल्ट का मतलब, लक्षण, और उपचार — पूरी जानकारी

A plain-language guide for patients & families · भारतीय मरीज़ों के लिए सरल मार्गदर्शिका

Hepatitis C is called the "silent killer" — because it causes no symptoms for 20–30 years while silently damaging the liver, eventually leading to cirrhosis and liver cancer. An estimated 6–12 million Indians have chronic Hepatitis C, most completely unaware of their infection. The HCV test result — positive Anti-HCV or detected HCV RNA — on your report can be frightening. But here is the most important fact: Hepatitis C is now curable in over 95% of patients with a short course of oral direct-acting antiviral (DAA) medications, with virtually no side effects. This guide explains the HCV test, what positive means, and what happens next.

If your doctor also ordered Liver Function Tests (LFT) or SGOT/SGPT alongside, see those guides too. For reading lab reports generally, see our beginner's guide to blood test reports.

HCV (हेपेटाइटिस C वायरस) "मूक हत्यारा" है — 20–30 वर्षों तक बिना लक्षण के लिवर को नुकसान पहुंचाता है। भारत में 6–12 मिलियन लोग प्रभावित हैं। लेकिन अच्छी खबर: DAA दवाओं से 95% में पूर्ण इलाज संभव है।

👁 Table of Contents / विषय सूची

1. What Is HCV? / HCV क्या है?
2. How HCV Spreads / कैसे फैलता है?
3. Symptoms — The Silent Disease / लक्षण
4. Reading Your Report — Positive vs Negative
5. Anti-HCV vs HCV RNA — The Critical Difference
6. Treatment — HCV Is Now Curable / उपचार
7. Test Preparation Checklist
8. Frequently Asked Questions / FAQ

Image 1: The Hepatitis C disease timeline. HCV infects the liver → 75–85% develop chronic infection (virus never cleared) → silent liver inflammation for 20–30 years → fibrosis → cirrhosis in 15–20% of untreated patients → hepatocellular carcinoma (liver cancer) in 1–5% per year once cirrhosis develops. India: HCV is responsible for 15–20% of all liver cirrhosis and 10–15% of liver cancer. The tragedy: all of this is now preventable with curative DAA treatment — but only if the infection is diagnosed before cirrhosis develops.

6–12M Indians estimated to have chronic Hepatitis C — one of the highest burdens in the world. Most are undiagnosed because HCV causes no symptoms for decades.

>95% cure rate with Direct-Acting Antiviral (DAA) treatment — 8–12 week oral course with minimal side effects. HCV is one of the few chronic viral infections that can be completely eradicated.

Anti-HCV ≠ Cure A positive Anti-HCV only means past exposure. You need HCV RNA (PCR) to confirm active current infection. Anti-HCV remains positive even after cure — it is not a test of current infection status.

---

What Is HCV? / HCV क्या है?

HCV (Hepatitis C Virus) is an RNA virus of the family Flaviviridae that primarily infects hepatocytes (liver cells). It was first identified in 1989 — before that, it was known as "non-A, non-B hepatitis" and was responsible for a massive wave of transfusion-related hepatitis in India from the 1960s through the early 1990s before HCV screening of blood donations was introduced. HCV has 7 major genotypes (1–7) and multiple subtypes. Genotype 3 is the most prevalent in India (~60–70% of Indian HCV cases), followed by genotype 1. Genotype identification is important because it historically determined treatment duration — though the newest pan-genotypic DAAs (like Sofosbuvir + Velpatasvir) work for all genotypes.

HCV (हेपेटाइटिस C वायरस) एक RNA वायरस है जो मुख्य रूप से लिवर कोशिकाओं को संक्रमित करता है। 1989 में पहचाना गया। भारत में जीनोटाइप 3 सबसे आम (~60–70%)। नई pan-genotypic DAA दवाएं सभी जीनोटाइप के लिए काम करती हैं।

HCV vs HBV — key differences Indian patients confuse:

• Hepatitis B (HBV): DNA virus; vaccine available (India UIP since 2002); spreads mother-to-child + sexual + blood; cannot be cured (only suppressed with Tenofovir/Entecavir lifelong); antibody (Anti-HBs) = protection.
• Hepatitis C (HCV): RNA virus; no vaccine available; spreads primarily through blood (rarely sexual); can be completely cured with 8–12 week DAA course; Anti-HCV does NOT mean protection — it means past exposure.
• Both cause chronic liver disease, cirrhosis, and liver cancer — but the prevention and treatment strategies are completely different.

HBV: DNA वायरस, वैक्सीन उपलब्ध, इलाज नहीं (दमन)। HCV: RNA वायरस, वैक्सीन नहीं, पूर्ण इलाज संभव। Anti-HCV = सुरक्षा नहीं = केवल पुराना संपर्क।

---

How HCV Spreads / HCV कैसे फैलता है

Image 2: HCV transmission routes in India. HCV is a blood-borne virus — it requires direct blood-to-blood contact to transmit. Unlike Hepatitis B, HCV is NOT efficiently transmitted sexually (risk is very low but not zero) and is NOT spread through food, water, hugging, coughing, or sharing utensils. Major transmission routes in India: unsafe blood transfusions before 1994 (when HCV screening was introduced — responsible for most current chronic Indian HCV); reused needles and syringes in healthcare and injection drug use; contaminated dental and surgical instruments; tattooing/piercing with unsterile equipment. Mother-to-child transmission is possible but rare (5–6%).

Blood transfusions before 1994 — #1 cause in India 1994 से पहले रक्त आधान — भारत में मुख्य कारण

India introduced mandatory HCV screening of blood donations only in 1994. Anyone who received a blood transfusion, blood products, or organ transplant before 1994 should be screened for HCV. This is the single most important risk factor for the older Indian generation (currently 45–80 year olds) — millions were unknowingly infected through transfusions for surgery, childbirth, and trauma before screening was available.

Unsafe injections & medical procedures असुरक्षित इंजेक्शन और चिकित्सा प्रक्रियाएं

Reused needles and syringes in India's informal healthcare sector — particularly at village-level practitioners, quacks, and some rural health facilities. Multi-dose vials contaminated by reusing syringes. Dental procedures with improperly sterilised instruments. Minor surgical procedures at unregulated facilities. HCV can survive on surfaces for up to 3 weeks — making contaminated equipment highly infectious.

What does NOT spread HCV (important for families) इनसे HCV नहीं फैलता

HCV is NOT spread by: sharing food, water, or cooking utensils; hugging, kissing on the cheek, handshaking; coughing or sneezing; breastfeeding (unless nipples are cracked and bleeding); sharing toilets or bathtubs; mosquito bites. Casual household contact does not transmit HCV. Family members of HCV-positive patients can live, eat, and share a household normally — the risk is essentially zero for household contact.

Sexual transmission — rare but possible यौन संचरण — दुर्लभ

HCV sexual transmission risk is very low in monogamous relationships — estimated at less than 1% per year for long-term partners. Risk increases with: multiple sexual partners; concurrent STIs (especially HIV); rough sexual activity with blood exposure. Unlike HBV, HCV is not efficiently sexually transmitted — most HCV-positive individuals with long-term partners do not infect their partners. However, informing sexual partners is the responsible approach so they can be tested.

---

Symptoms — The Silent Disease / लक्षण

Acute HCV (first 6 months) — mostly silent तीव्र HCV — अधिकतर चुप

Only 20–30% of people develop any symptoms during the acute phase. When symptoms do occur (2–12 weeks after exposure): fatigue, nausea, vomiting, abdominal discomfort, mild jaundice. These are mild and non-specific — easily mistaken for "viral fever." 15–25% of people clear HCV naturally (spontaneous viral clearance) during the acute phase — more common in younger women, those with certain immune gene variants (IL28B CC genotype). The remaining 75–85% develop chronic infection.

Chronic HCV (beyond 6 months) — decades of silence क्रोनिक HCV — दशकों की चुप्पी

Most patients have NO symptoms for 20–30 years while the virus silently inflames and scars the liver. When symptoms appear, significant damage has often already occurred:

• Persistent fatigue (most common complaint)
• Right upper abdominal discomfort
• Nausea, loss of appetite
• Joint and muscle pain
• Cognitive symptoms ("brain fog")
• Symptoms of cirrhosis — jaundice, abdominal swelling (ascites), leg oedema, easy bruising, confusion (encephalopathy)
• Liver cancer (HCC) may be the first clinical presentation

Extra-hepatic manifestations — outside the liver यकृत के बाहर के लक्षण

HCV can affect many organs beyond the liver — often the presenting complaint in India:

• Cryoglobulinaemia — causing positive RA Factor (many Indian patients are wrongly diagnosed with Rheumatoid Arthritis from unrecognised HCV cryoglobulins)
• Membranoproliferative glomerulonephritis — kidney disease, proteinuria
• Peripheral neuropathy
• Sicca syndrome (dry eyes, dry mouth)
• Type 2 diabetes — HCV directly promotes insulin resistance
• B-cell lymphoma — HCV significantly increases risk
• Thyroid disorders

Who should be screened for HCV in India? भारत में किसे HCV की जांच करानी चाहिए?

• Everyone who received a blood transfusion before 1994
• History of IV drug use (any period)
• HIV-positive individuals
• Patients on haemodialysis (dialysis)
• Healthcare workers with needlestick injuries
• Unexplained elevated SGPT/SGOT without identified cause
• Sexual partners of HCV-positive individuals
• Children born to HCV-positive mothers
• Prisoners and those in high-prevalence institutional settings
• Elevated bilirubin or liver disease of unknown cause

---

Reading Your Report — Positive vs Negative

Report Says	Meaning	What to Do
Anti-HCV: REACTIVE / POSITIVE पॉजिटिव	HCV Antibody Detected Your immune system has at some point encountered HCV — either past resolved infection OR current active infection. Does NOT confirm current active infection.	Immediately order HCV RNA (PCR) to determine if virus is currently present. Do not start treatment based on Anti-HCV alone. Do not panic — this is the screening test, not the confirmatory test.
Anti-HCV: NON-REACTIVE / NEGATIVE नेगेटिव	HCV Antibody Not Detected No HCV antibody. In immunocompetent people, this essentially rules out HCV infection (unless very early — within first 8–12 weeks of infection, the "window period").	No further HCV testing needed in low-risk individuals. If very recent exposure suspected (within 12 weeks), repeat Anti-HCV at 12 weeks. In HIV+ or severely immunocompromised: order HCV RNA directly (may not produce antibodies).
HCV RNA: DETECTED / POSITIVE PCR पॉजिटिव	Active HCV Infection Confirmed HCV viral RNA present in blood — you have active current Hepatitis C infection. Treatment is needed.	Hepatologist/gastroenterologist consultation immediately. Order: HCV genotype + viral load + LFT + CBC + fibroscan/ultrasound. Start DAA treatment planning.
HCV RNA: NOT DETECTED / NEGATIVE PCR नेगेटिव	No Active Infection Two scenarios: (1) Anti-HCV positive + HCV RNA negative = past infection, spontaneously cleared OR successfully treated; (2) Anti-HCV negative + HCV RNA negative = never infected (or very early window period).	If Anti-HCV was positive: congratulations — you have either cleared HCV naturally or (if previously treated) achieved SVR (Sustained Virological Response = cure). Confirm SVR with repeat HCV RNA at 12 weeks post-treatment.

---

Anti-HCV vs HCV RNA — The Critical Difference

Image 3: Anti-HCV vs HCV RNA — the two-step testing approach. Anti-HCV (ELISA/CLIA): Detects antibodies your immune system made against HCV — appears 8–12 weeks after infection and persists lifelong even after the virus is cleared (by treatment or naturally). A positive Anti-HCV does NOT mean active infection — it means past exposure. HCV RNA (Quantitative PCR): Detects actual viral RNA in blood — the gold standard for confirming active infection. Also used to monitor treatment response. Undetectable after treatment = cured (Sustained Virological Response, SVR12). Protocol: positive Anti-HCV → ALWAYS confirm with HCV RNA. Never start treatment without confirmed HCV RNA positivity.

Test	What It Detects	Positive Means	Stays Positive After Cure?	Use
Anti-HCV (ELISA/CLIA)	Antibodies made by your immune system against HCV	Past or current HCV exposure — not active infection	YES — lifelong	Screening. First-line test. Inexpensive (₹200–600).
HCV RNA Qualitative (PCR)	Presence or absence of HCV viral RNA	Active current HCV infection — virus present now	NO — becomes undetectable after cure	Confirmatory test after positive Anti-HCV. Diagnosis of active infection.
HCV RNA Quantitative (Viral Load)	Amount of HCV RNA (IU/mL)	Active infection — baseline viral load before treatment	NO — becomes undetectable	Pre-treatment baseline. Monitor treatment response. SVR12 confirmation (undetectable = cured).
HCV Genotype	Identifies HCV strain (1, 2, 3, 4, 5, 6)	Genotype 3 most common in India (~65%)	N/A	Guides treatment duration (8 vs 12 weeks). Now less critical with pan-genotypic DAAs.

⚠️ The complete HCV diagnostic pathway — step by step:

• Step 1 — Screening: Anti-HCV ELISA/CLIA → Reactive → go to Step 2. Non-reactive → no HCV (unless window period).
• Step 2 — Confirm active infection: HCV RNA PCR (qualitative) → Detected = active infection, proceed to Step 3. Not detected = past resolved infection (spontaneous clearance) or after successful treatment.
• Step 3 — Pre-treatment workup: HCV genotype + HCV RNA viral load + full LFT + CBC + fibroscan (assess fibrosis stage) + HBsAg + HIV test (co-infections affect treatment).
• Step 4 — Treatment: 8–12 weeks of DAA (Sofosbuvir-based regimen).
• Step 5 — Confirm cure: HCV RNA PCR 12 weeks after completing treatment = SVR12. Undetectable = cured (>99% durability — HCV does not come back once SVR12 is achieved).

HCV pathway: Anti-HCV → HCV RNA → Genotype + Viral load + LFT + Fibroscan → DAA treatment (8–12 weeks) → SVR12 (HCV RNA undetectable = CURED)।

---

Treatment — HCV Is Now Curable / उपचार

Direct-Acting Antivirals (DAAs) — the cure DAA दवाएं — इलाज

The treatment of HCV has been transformed since 2013 with the introduction of DAAs. Current standard regimens in India (2026):

• Sofosbuvir + Velpatasvir (Epclusa generic) — 12 weeks, pan-genotypic (all genotypes including genotype 3); first-line for most Indian patients; generic available in India at ₹5,000–15,000 for full course
• Sofosbuvir + Ledipasvir (Harvoni generic) — 12 weeks, genotype 1 and 4
• Glecaprevir + Pibrentasvir (Maviret generic) — 8 weeks, pan-genotypic; even for cirrhosis patients (compensated)
• Sofosbuvir + Daclatasvir — older but effective, widely available in India

Cure rate: >95% in treatment-naive patients without cirrhosis; >90% in cirrhotic patients.

Who needs treatment? — Everyone with active HCV इलाज किसे चाहिए?

As of 2026, all patients with confirmed active HCV (positive HCV RNA) should be treated — regardless of liver disease stage, age, or symptom status. The old approach of "watch and wait" is abandoned. Even patients with minimal liver damage benefit enormously from cure — preventing future cirrhosis and liver cancer. Special populations requiring careful management but still treatable: compensated cirrhosis (Child-Pugh A); HIV-HCV co-infection (check drug interactions); severe renal impairment (dose adjustment for some DAAs); decompensated cirrhosis (Child-Pugh B/C — refer to liver transplant centre).

Accessing DAA treatment in India — cost and availability भारत में DAA — लागत और उपलब्धता

India produces high-quality generic DAAs — one of the lowest prices in the world:

• Government programme (NVHCP): Free DAA treatment at government medical colleges, district hospitals, and PHCs under the National Viral Hepatitis Control Programme. Ask at the nearest government hospital gastroenterology department.
• Private sector generic: Full 12-week course of Sofosbuvir + Velpatasvir available for ₹5,000–15,000 at generic pharmacies — the same molecules as branded Epclusa costing ₹3–5 lakhs abroad.
• Charitable programmes: Several Indian NGOs and Médecins Sans Frontières (MSF) provide free or subsidised DAA treatment for marginalised populations.

After cure — monitoring for cirrhosis and cancer इलाज के बाद — निगरानी

HCV cure (SVR12) does not automatically reverse cirrhosis that has already developed. Key monitoring after SVR:

• Patients without cirrhosis: annual LFT — liver disease risk returns to near-normal after cure
• Patients with cirrhosis: 6-monthly liver ultrasound + AFP (liver cancer surveillance — LIFELONG, even after HCV cure, because cirrhotic liver remains at elevated cancer risk)
• Cirrhosis may partially reverse after SVR (fibrosis regression) — but this takes years
• Alcohol cessation is mandatory — alcohol dramatically accelerates cirrhosis even after HCV is cured

---

Test Preparation Checklist / टेस्ट की तैयारी

HCV testing requires minimal preparation — but these points ensure accurate results and the most productive specialist appointment:

HCV परीक्षण के लिए न्यूनतम तैयारी — लेकिन ये बिंदु सटीक परिणाम सुनिश्चित करते हैं।

• ✓
  No fasting required for Anti-HCV or HCV RNA. Both tests detect immunological markers or viral RNA in blood — food intake does not affect either result. However, if ordered alongside LFT, fasting blood sugar, or lipid profile, follow the fasting instructions for those tests.
• ✓
  Always confirm a positive Anti-HCV with HCV RNA PCR before acting on it. Anti-HCV alone is a screening test — it remains positive lifelong even after cure. Never start treatment, tell your employer, or restrict your activities based on Anti-HCV alone. HCV RNA PCR is mandatory to confirm whether you currently have active HCV infection.
• ✓
  If you have had HCV treatment in the past — inform your doctor and the lab. Anti-HCV will always remain positive even after successful cure. The correct test for treatment success monitoring is HCV RNA PCR (should be "Not Detected" = cured at SVR12).
• ✓
  For immunocompromised patients (HIV+, transplant, dialysis) — Anti-HCV may be falsely negative because the immune system cannot produce antibodies effectively. Order HCV RNA PCR directly in these patients — do not rely on Anti-HCV alone.
• ✓
  Order the full pre-treatment workup at the same appointment. If HCV RNA is confirmed positive, save time by ordering simultaneously: HCV genotype + viral load + full LFT + CBC + HBsAg + HIV test + serum creatinine + fibroscan appointment. This allows the hepatologist to plan treatment at the very first consultation.
• ✓
  Use an NABL-accredited lab for Anti-HCV testing. Rapid card tests (lateral flow) for Anti-HCV available at rural health centres are adequate for screening — but ELISA or CLIA-based quantitative Anti-HCV at an NABL-accredited lab is required for clinical diagnosis documentation, blood bank clearance, and treatment eligibility confirmation.
• ✓
  Disclose all medications to your hepatologist before starting DAAs. Several common medications have clinically significant interactions with DAAs: amiodarone (heart rhythm drug — serious bradycardia with Sofosbuvir), rifampicin (anti-TB — reduces DAA levels dramatically), certain anticonvulsants, HIV antiretrovirals. A complete medication list is essential before prescribing DAA treatment.

---

✅ Book HCV Test (Anti-HCV + HCV RNA) — Home Collection Available

HCV testing should always include both Anti-HCV (screening) and HCV RNA (confirmation). A positive Anti-HCV without HCV RNA confirmation is incomplete and should never be the basis for treatment decisions:

Anti-HCV Test + HCV RNA PCR (Complete HCV Diagnosis) Anti-HCV ELISA/CLIA screening + HCV RNA quantitative PCR confirmation · NABL-accredited lab · Home collection · No fasting required · Digital report · Available across India

Book HCV Test →

Affiliate link: I may earn a small commission at no extra cost to you. Anti-HCV and HCV RNA testing is available free at government hospitals and PHCs under India's National Viral Hepatitis Control Programme (NVHCP). A confirmed positive HCV RNA requires immediate hepatologist consultation — do not wait. DAA treatment is available free at government medical colleges across India.

Anti-HCV + HCV RNA PCR सरकारी अस्पतालों में NVHCP के तहत निःशुल्क। पॉजिटिव HCV RNA पर तुरंत हेपेटोलॉजिस्ट से मिलें। DAA इलाज सरकारी अस्पतालों में मुफ्त।

🛒 Liver Support — Adjunct Supplements During HCV Recovery

DAA medications are the only evidence-based cure for HCV. However, these supportive supplements are widely used in India alongside primary antiviral treatment to support hepatocyte health, reduce inflammation, and aid liver recovery. Always consult your hepatologist before starting any supplement during HCV treatment — some supplements have drug interactions with DAAs.

Carbamide Forte Curcumin Tablets — 95% Curcuminoids with Piperine

Curcumin (the active compound in turmeric) has significant anti-inflammatory and antioxidant effects on hepatocytes — it inhibits NF-κB, reduces pro-inflammatory cytokines (IL-6, TNF-alpha), and has demonstrated anti-fibrotic properties in experimental liver fibrosis models. Carbamide Forte's formulation with piperine (from black pepper) dramatically increases curcumin bioavailability. Multiple studies show curcumin reduces elevated SGPT/SGOT in chronic liver disease alongside primary treatment. Adjunct support during liver recovery. Always consult your hepatologist — curcumin may interact with some DAAs and anticoagulants at high doses.

View on Amazon India

Affiliate link — small commission at no extra cost.

Carbamide Forte Liver Detox — Milk Thistle 800 mg (Silymarin)

Milk Thistle (Silymarin) is the most extensively studied hepatoprotective botanical — it acts as an antioxidant on hepatocytes, inhibits pro-inflammatory mediators, and has anti-fibrotic properties. Particularly relevant in HCV liver disease: multiple studies show silymarin reduces ALT/SGPT elevation, reduces oxidative stress in HCV-infected hepatocytes, and may have modest anti-HCV activity (though not antiviral treatment). Used as adjunct support alongside DAA treatment in Indian hepatology practice. Consult your hepatologist before starting — this is not a substitute for DAA antiviral treatment.

View on Amazon India

Affiliate link — small commission at no extra cost.

Know someone who tested positive for HCV or wants to understand their Anti-HCV report? Share this guide. क्या आप किसी को जानते हैं जिनका Anti-HCV पॉजिटिव आया या HCV के बारे में जानना चाहते हैं? यह गाइड शेयर करें।

Share on WhatsApp

Related Tests / संबंधित जांचें

These tests are commonly ordered alongside HCV testing in India:

HCV परीक्षण के साथ ये जांचें अक्सर करवाई जाती हैं:

Liver Function Test (LFT) SGOT SGPT Test CBC (Complete Blood Count) HbA1c Test How to Read a Blood Test Report

---

Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल

My Anti-HCV is positive. Does this mean I have Hepatitis C right now?

A positive Anti-HCV means your immune system has encountered HCV at some point — but it does NOT confirm current active infection. Anti-HCV remains positive lifelong — even after the virus has been completely cleared (either naturally or by treatment). Three scenarios share a positive Anti-HCV: (1) Active current HCV infection — HCV RNA PCR will be positive; (2) Past HCV infection, spontaneously cleared — HCV RNA will be not detected; (3) Past HCV infection, successfully treated (cured) — HCV RNA will be not detected. The mandatory next step after a positive Anti-HCV is always HCV RNA PCR — only this test can tell you whether the virus is currently present. Never make treatment decisions, change lifestyle dramatically, or inform contacts based on Anti-HCV alone.

उत्तर: Anti-HCV+ = केवल HCV से संपर्क हुआ, अभी नहीं। अगला कदम: HCV RNA PCR। PCR+ = सक्रिय। PCR undetectable = ठीक हो चुका।

Is Hepatitis C really curable? I heard it cannot be treated.

This is outdated information — Hepatitis C treatment has been completely transformed. Before 2011, HCV was treated with Interferon injections + Ribavirin for 24–48 weeks — this had only a 40–50% cure rate and caused severe side effects (flu-like symptoms, depression, anaemia). Since 2013, Direct-Acting Antivirals (DAAs) have replaced interferon entirely. Current DAA regimens achieve cure rates above 95%: 8–12 weeks of oral tablets once daily, no injections, minimal side effects, no bed rest needed. Generic DAAs produced in India make this cure available for ₹5,000–15,000 — a fraction of the cost in Western countries. Hepatitis C is now one of the few chronic viral infections that can be completely eradicated from the body. SVR12 (HCV RNA undetectable 12 weeks after completing treatment) is considered a definitive virological cure — the virus does not come back in over 99% of cases achieving SVR12.

उत्तर: हाँ — HCV अब पूरी तरह ठीक हो सकता है। DAA दवाएं: 8–12 सप्ताह, 95%+ इलाज, कोई इंजेक्शन नहीं, न्यूनतम साइड इफेक्ट। भारत में generic DAA: ₹5,000–15,000। SVR12 = पक्का इलाज।

Is fasting required before the HCV test?

No — fasting is not required for Anti-HCV or HCV RNA PCR. Both tests detect immunological or viral markers in blood serum that are not affected by food intake. You can eat and drink normally before these tests. However, if HCV testing is ordered alongside LFT (which includes fasting-dependent tests like albumin and fasting blood sugar/lipid profile), follow the fasting instructions for those tests — all samples will be collected from the same blood draw.

उत्तर: नहीं — Anti-HCV और HCV RNA के लिए उपवास आवश्यक नहीं।

I was treated for Hepatitis C 2 years ago. My Anti-HCV is still positive. Am I still infected?

Almost certainly not — if your treatment course was completed. Anti-HCV remains positive lifelong after cure — this is a fundamental property of the immune system. After successful DAA treatment, antibodies against HCV persist indefinitely but the virus is gone. The correct test to confirm cure is HCV RNA PCR — which should show "Not Detected" (undetectable) if you achieved SVR12. If you completed a full course of DAA treatment and had an undetectable HCV RNA 12 weeks after completing treatment (SVR12), you are cured. The persistent positive Anti-HCV is expected and does not mean the virus is still present. You do not need retreatment based on Anti-HCV alone. If you are unsure whether SVR12 was confirmed, ask your hepatologist to repeat HCV RNA PCR — this will definitively confirm cure.

उत्तर: नहीं — Anti-HCV इलाज के बाद भी जीवनभर पॉजिटिव रहता है। इलाज सफल होने की पुष्टि: HCV RNA PCR "Not Detected"। SVR12 = पक्का इलाज।

My family member has HCV. Will I get it by living with them?

The risk of acquiring HCV through casual household contact is essentially zero. HCV is a blood-borne virus — it requires direct blood-to-blood contact to transmit. Sharing meals, utensils, towels, toilets, or bathtubs does NOT transmit HCV. Hugging, kissing on the cheek, or shaking hands does NOT transmit HCV. Household members of HCV-positive individuals do not need to take any special precautions for routine daily activities. However, specific precautions that are reasonable: do not share razors, toothbrushes, or nail clippers (blood contact risk if cuts occur); cover any bleeding wounds appropriately. Sexual transmission risk is very low in monogamous relationships but not zero — sexual partners should be tested and, if uninfected, can discuss their risk level with a doctor. Children born to HCV-positive mothers have a 5–6% transmission risk and should be tested at 18 months of age (Anti-HCV testing is not reliable before 18 months due to maternal antibodies).

उत्तर: दैनिक घरेलू संपर्क से HCV प्रसारण का जोखिम लगभग शून्य है। खाना, बर्तन, शौचालय, गले मिलना — सुरक्षित। सावधानी: रेजर, टूथब्रश साझा न करें। यौन साथी की जांच करें।

I received a blood transfusion in India in 1988. Should I get tested for HCV?

Yes — absolutely. This is one of the most important screening recommendations for older Indians. Mandatory HCV screening of blood donations was introduced in India only in 1994. Any blood transfusion, blood product (fresh frozen plasma, platelets, cryoprecipitate), or organ transplant received before 1994 carries a significant risk of HCV transmission from those pre-screening years — potentially without any symptoms for the subsequent 30+ years. You should be tested with Anti-HCV immediately, regardless of whether you have any symptoms. If Anti-HCV is positive, confirm with HCV RNA PCR. If active infection is confirmed, start DAA treatment without delay — even 30 years of HCV infection can be cured with DAA treatment, and clearing the virus at any stage dramatically reduces the risk of future liver cancer and cirrhosis progression. Many Indians first diagnosed in their 50s and 60s from pre-1994 transfusions can still be completely cured.

उत्तर: हाँ — तुरंत Anti-HCV जांच करवाएं। 1994 से पहले रक्त आधान = HCV का महत्वपूर्ण जोखिम। बिना लक्षण के भी 30 साल बाद DAA से पूर्ण इलाज संभव है।

---

External References / बाहरी संसाधन

• WHO — Hepatitis C: WHO Hepatitis C Fact Sheet
• NVHCP (Govt of India): National Viral Hepatitis Control Programme — India
• MedlinePlus: Hepatitis C — Patient Information

⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण

This article is for educational purposes only. A positive Anti-HCV result must always be confirmed with HCV RNA PCR and interpreted by a qualified gastroenterologist or hepatologist alongside LFT, fibroscan, genotype, and complete history. Never start DAA treatment without medical supervision — drug interactions with other medications can be serious. Free DAA treatment is available through the NVHCP at government hospitals across India.

यह लेख केवल शैक्षिक उद्देश्यों के लिए है। Anti-HCV+ पर HCV RNA PCR द्वारा पुष्टि करें। DAA उपचार चिकित्सकीय पर्यवेक्षण में शुरू करें। सरकारी अस्पतालों में NVHCP के तहत मुफ्त DAA उपलब्ध।

Share on WhatsApp